Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thanh H Dellinger

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
International Urogynecology Journal|May 2, 2022
Feasibility of combining pelvic reconstruction with gynecologic oncology-related surgeryAdrian Kohut, Taylor Whitaker, Logan Walter, et al.
Molecular Therapy Oncolytics|November 30, 2020
Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer MetastasisMohamed Hammad, Yvonne Cornejo, Linda Flores, et al.
Molecular Therapy Oncolytics|June 25, 2020
Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian CancerRachael Mooney, Asma Abdul Majid, Jennifer Batalla-Covello, et al.
Molecular Therapy Oncolytics|August 11, 2020
Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer ModelMohamed Hammad, Yvonne R Cornejo, Jennifer Batalla-Covello, et al.
Journal of Surgical Oncology|August 8, 2025
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and RecommendationDonnal Brennan, Amy Hawarden, Michela Cinquini, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Molecular Cancer Therapeutics|October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerWei Wen, Wei Liang, Jun Wu, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol AcetateRosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
International Urogynecology Journal|May 2, 2022
Feasibility of combining pelvic reconstruction with gynecologic oncology-related surgeryAdrian Kohut, Taylor Whitaker, Logan Walter, et al.
Molecular Therapy Oncolytics|November 30, 2020
Novel Chimeric Poxvirus CF17 Improves Survival in a Murine Model of Intraperitoneal Ovarian Cancer MetastasisMohamed Hammad, Yvonne Cornejo, Linda Flores, et al.
Molecular Therapy Oncolytics|June 25, 2020
Erratum: Enhanced Delivery of Oncolytic Adenovirus by Neural Stem Cells for Treatment of Metastatic Ovarian CancerRachael Mooney, Asma Abdul Majid, Jennifer Batalla-Covello, et al.
Molecular Therapy Oncolytics|August 11, 2020
Neural Stem Cells Improve the Delivery of Oncolytic Chimeric Orthopoxvirus in a Metastatic Ovarian Cancer ModelMohamed Hammad, Yvonne R Cornejo, Jennifer Batalla-Covello, et al.
Journal of Surgical Oncology|August 8, 2025
Multisocietal Consensus on the Use of Cytoreductive Surgery and HIPEC for the Treatment of Epithelial Ovarian Cancer: A GRADE Approach for Evidence Evaluation and RecommendationDonnal Brennan, Amy Hawarden, Michela Cinquini, et al.
NPJ Precision Oncology|December 14, 2025
Divergent oncogenic signaling and immune microenvironment changes in low-grade serous ovarian cancer patients undergoing intraperitoneal chemotherapyIsaac Bishara, Patrick A Cosgrove, Sumana Majumdar, et al.
Molecular Cancer Therapeutics|October 17, 2014
Targeting JAK1/STAT3 signaling suppresses tumor progression and metastasis in a peritoneal model of human ovarian cancerWei Wen, Wei Liang, Jun Wu, et al.
Antioxidants (Basel, Switzerland)|April 14, 2025
The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol AcetateRosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Annals of Surgical Oncology|August 13, 2021
PIPAC for the Treatment of Gynecologic and Gastrointestinal Peritoneal Metastases: Technical and Logistic Considerations of a Phase 1 TrialMustafa Raoof, Gautam Malhotra, Adrian Kohut, et al.
Antioxidants (Basel, Switzerland)|December 30, 2025
Correction: Senguttuvan et al. The Anti-Cancer Role of Pterostilbene in Endometrial Cancer: A Phase II Prospective, Randomized, Window-of-Opportunity Clinical Trial with Megestrol Acetate. <i>Antioxidants</i> 2025, <i>14</i>, 345Rosemary N Senguttuvan, Hyejin Cho, Xiwei Wu, et al.
Pageof 5